Kenneth N. Ross

17.4k citations

60 papers · 10.7k indexed · 4 hit papers · h-index 33

Impact in

Cancer Research top 0.5%
Molecular Biology top 0.5%
- Bioinformatics and Genomic Networks
- Gene expression and cancer classification
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- RNA modifications and cancer

Papers in

Co-authors: Todd R. Golub Eric S. Lander Justin Lamb Phillip G. Febbo D. D. Peck Haley Hieronymus Emily Crawford Steven A. Carr
Journals: Cancer Cell (5 papers)Blood (5 papers)Proceedings of the National Academy of Sciences (4 papers)Cancer Research (3 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States Argentina Germany

In The Last Decade

Kenneth N. Ross

59 papers receiving 10.5k citations

Hit Papers

align trajectories log scale

Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism 2015 · 615 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Nature
2006 Science
2006 Cancer Research
2002 Cancer Cell

Peers

Countries citing papers authored by Kenneth N. Ross

Since Specialization

Citations

This map shows the geographic impact of Kenneth N. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth N. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth N. Ross more than expected).

Fields of papers citing papers by Kenneth N. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth N. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth N. Ross. The network helps show where Kenneth N. Ross may publish in the future.

Co-authors

The 25 scholars most cited alongside Kenneth N. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kenneth N. Ross Line = papers co-authored together Kenneth N. Ross links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rewiring the Fusion Oncoprotein EWSR1::FLI1 in Ewing Sarcoma with Bivalent Small Molecules Journal of the American Chemical Society ·Michael J. Bond, Ryan P. Golden, Giulia DiGiovanni, Briana Howard, Roman C. Sarott, Basel A. Karim, Sai Gourisankar, Gabriela Alexe, Kenneth N. Ross, Hannah M. Jones, Brendan G. Dwyer, Nathanael S. Gray, Kimberly Stegmaier	2025	0
2	The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma Nature Cell Biology ·Diana Lu, Jana M. Ellegast, Kenneth N. Ross, Clare F. Malone, Shan Lin, Nathaniel W. Mabe, Neekesh V. Dharia, Ashleigh Meyer, Amy Saur Conway, Angela Su, Julia Selich‐Anderson, Cenny Taslim, Andrea K. Byrum, Bo Kyung A. Seong, Biniam Adane, Nathanael S. Gray, Miguel N. Rivera, Stephen L. Lessnick, Kimberly Stegmaier	2023	24
3	RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer Clinical Cancer Research ·Siang‐Boon Koh, Kenneth N. Ross, Steven J. Isakoff, Nsan Melkonjan, Lei He, Karina J. Matissek, Andrew Schultz, Erica L. Mayer, Tiffany A. Traina, Lisa A. Carey, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Adam Langenbucher, Srinivas Vinod Saladi, Sridhar Ramaswamy, Michael S. Lawrence, Leif W. Ellisen	2021	16
4	Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers Science Advances ·Mihriban Karaayvaz, Rebecca E. Silberman, Adam Langenbucher, Srinivas Vinod Saladi, Kenneth N. Ross, Elena Zarcaro, Andrea Desmond, Murat Yıldırım, Varunika Vivekanandan, Hiranmayi Ravichandran, Ravindra Mylavagnanam, Michelle C. Specht, Sridhar Ramaswamy, Michael S. Lawrence, Angelika Amon, Leif W. Ellisen	2020	26
5	REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors Genes & Development ·Shuxi Qiao, Siang‐Boon Koh, Varunika Vivekanandan, Devika Salunke, Krushna C. Patra, Elma Zaganjor, Kenneth N. Ross, Yusuke Mizukami, Sarah Jeanfavre, Athena L. Chen, Mari Mino–Kenudson, Sridhar Ramaswamy, Clary B. Clish, Marcia C. Haigis, Nabeel Bardeesy, Leif W. Ellisen	2020	37
6	AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth Molecular Cancer Therapeutics ·Cleidson P. Alves, Ipsita Dey‐Guha, Sheheryar Kabraji, Albert C. Yeh, Nilesh P. Talele, Xavier Solé, Joeeta Chowdhury, Mari Mino–Kenudson, Massimo Loda, Dennis C. Sgroi, Anne‐Lise Børresen‐Dale, Hege G. Russnes, Kenneth N. Ross, Sridhar Ramaswamy	2017	19
7	Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer Oncotarget ·Tristan Gallenne, Kenneth N. Ross, Nils L. Visser, Salony, Christophe Desmet, Ben S. Wittner, Lodewyk F.A. Wessels, Sridhar Ramaswamy, Daniel S. Peeper	2017	30
8	Integrin β1 activation induces an anti-melanoma host response PLoS ONE ·Laila Ritsma, Ipsita Dey‐Guha, Nilesh P. Talele, Xavier Solé, Salony, Joeeta Chowdhury, Kenneth N. Ross, Sridhar Ramaswamy	2017	9
9	Light-controlled modulation of gene expression by chemical optoepigenetic probes Nature Chemical Biology ·Surya A. Reis, Balaram Ghosh, J. Adam Hendricks, D. Miklos Szantai‐Kis, Lisa Törk, Kenneth N. Ross, Justin Lamb, Willis Read-Button, Baixue Zheng, Hongtao Wang, Christopher Salthouse, Stephen J. Haggarty, Ralph Mazitschek	2016	74
10	ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis Cancer Cell ·Srinivas Vinod Saladi, Kenneth N. Ross, Mihriban Karaayvaz, Purushothama Rao Tata, Hongmei Mou, Jayaraj Rajagopal, Sridhar Ramaswamy, Leif W. Ellisen	2016	144
11	Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence Journal of Clinical Oncology ·Tanya E. Keenan, Beverly Moy, Edmund A. Mroz, Kenneth N. Ross, Andrzej Niemierko, James W. Rocco, Steven J. Isakoff, Leif W. Ellisen, Aditya Bardia	2015	168
12	AKT Inhibition Promotes Nonautonomous Cancer Cell Survival Molecular Cancer Therapeutics ·Salony, Xavier Solé, Cleidson P. Alves, Ipsita Dey‐Guha, Laila Ritsma, Myriam Boukhali, Ju H. Lee, Joeeta Chowdhury, Kenneth N. Ross, Wilhelm Haas, Shobha Vasudevan, Sridhar Ramaswamy	2015	17
13	The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine Nature Cell Biology ·Jean‐Pierre Etchegaray, Lukas Chávez, Yun Huang, Kenneth N. Ross, Jiho Choi, Bárbara Martínez-Pastor, Ryan Walsh, Cesar Sommer, Matthias Lienhard, Adrianne D. Gladden, Sita Kugel, Dafne M. Silberman, Sridhar Ramaswamy, Gustavo Mostoslavsky, Konrad Hochedlinger, Alon Goren, Anjana Rao, Raúl Mostoslavsky	2015	125
14	Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism Nature ·Rushika M. Perera, Svetlana Stoykova, Brandon Nicolay, Kenneth N. Ross, Julien Fitamant, Myriam Boukhali, Justine Lengrand, Vikram Deshpande, Martin K. Selig, Cristina R. Ferrone, Jeff Settleman, Gregory Stephanopoulos, Nicholas J. Dyson, Roberto Zoncu, Sridhar Ramaswamy, Wilhelm Haas, Nabeel Bardeesy Hit paper breakdown →	2015	615
15	Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation Chemistry & Biology ·Stacey M. Frumm, Zi Peng Fan, Kenneth N. Ross, Jeremy R. Duvall, Supriya Gupta, Lynn VerPlank, Byung‐Chul Suh, Edward B. Holson, Florence F. Wagner, William Smith, Ronald M. Paranal, Christopher F. Bassil, Jun Qi, Giovanni Roti, Andrew L. Kung, James E. Bradner, Nicola Tolliday, Kimberly Stegmaier	2013	85
16	The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia Journal of Clinical Investigation ·Versha Banerji, Stacey M. Frumm, Kenneth N. Ross, Loretta S. Li, Anna C. Schinzel, Cynthia K. Hahn, Rose M. Kakoza, Kwan T. Chow, Linda S. Ross, Gabriela Alexe, Nicola Tolliday, Haig Inguilizian, Ilene Galinsky, Richard M. Stone, Daniel J. DeAngelo, Giovanni Roti, Jon C. Aster, William C. Hahn, Andrew L. Kung, Kimberly Stegmaier	2012	85
17	Proteomic and Genetic Approaches Identify Syk as an AML Target Cancer Cell ·Cynthia K. Hahn, Jacob E. Berchuck, Kenneth N. Ross, Rose M. Kakoza, Karl R. Clauser, Anna C. Schinzel, Linda S. Ross, Ilene Galinsky, Tina Davis, Serena J. Silver, David E. Root, Richard M. Stone, Daniel J. DeAngelo, Martin Carroll, William C. Hahn, Steven A. Carr, Todd R. Golub, Andrew L. Kung, Kimberly Stegmaier	2009	120
18	High-throughput gene expression profiling of memory differentiation in primary human T cells BMC Immunology ·W. Nicholas Haining, Jill Angelosanto, Kathleen Brosnahan, Kenneth N. Ross, Cynthia K. Hahn, Kate Russell, Linda Drury, Stephanie Norton, Lee M. Nadler, Kimberly Stegmaier	2008	21
19	Hidden Markov Models for Threat Prediction Fusion. Proc SPIE ·Kenneth N. Ross, Ronald D. Chaney	2000	1
20	A dynamical system model for generating F0 for synthesis. SSW ·Kenneth N. Ross, Mari Ostendorf	1994	12

About Kenneth N. Ross

Kenneth N. Ross is a scholar working on Geriatrics and Gerontology, Cancer Research, Molecular Biology, Cell Biology and Oncology, having authored 60 papers that have together received 10.7k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (10 papers), Histone Deacetylase Inhibitors Research (6 papers), Neuroblastoma Research and Treatments (5 papers), Genomics and Chromatin Dynamics (5 papers), Speech Recognition and Synthesis (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Phonetics and Phonology Research (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (7.2k citations), Computational Theory and Mathematics (1.4k citations), Geriatrics and Gerontology (220 citations) and Pulmonary and Respiratory Medicine (1.8k citations). Kenneth N. Ross has collaborated with scholars based in United States, Argentina and Germany. Frequent co-authors include Todd R. Golub, Eric S. Lander, Justin Lamb, Phillip G. Febbo, D. D. Peck, Haley Hieronymus, Emily Crawford, Steven A. Carr, Stephen J. Haggarty and Scott A. Armstrong. Their work appears in journals such as Cancer Cell, Blood, Proceedings of the National Academy of Sciences, Cancer Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact